Related Experiment Video
Updated: Jun 20, 2026
08:35
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Cytochrome p450 and steatosis
María José Gómez-Lechón1, Ramiro Jover, María Teresa Donato
1Unidad de Hepatología Experimental, Centro de investigación, Hospital Universitario La Fe, Valencia, Spain. gomez_mjo@gva.es
Current Drug Metabolism
|August 26, 2009
Summary
Fatty liver, or steatosis, involves excess lipids in liver cells. This condition can impair drug metabolism by affecting cytochrome P450 (CYP) enzymes, impacting liver function.
Area of Science:
- Hepatology
- Pharmacology
- Biochemistry
Background:
- Fatty liver, defined by >5% lipids in liver weight, leads to steatosis via triglyceride accumulation.
- This fat deposition can disrupt normal liver function and potentially progress to severe liver diseases like NASH or cirrhosis.
- The impact of steatosis on human liver metabolism, particularly drug metabolism, is not well understood.
Purpose of the Study:
- To review the effects of fatty liver on the liver's drug-metabolizing capacity.
- To discuss potential molecular mechanisms influencing cytochrome P450 (CYP) expression in fatty liver disease.
Main Methods:
- Literature review and analysis of existing studies on fatty liver and drug metabolism.
- Examination of findings from patient data, animal models, and cell-based studies.
- Discussion of transcriptional regulation of CYP enzymes in steatotic livers.
Main Results:
- Fat accumulation in the liver is linked to altered drug metabolism.
- Changes in cytochrome P450 (CYP) enzyme activity are observed in steatosis.
- Evidence suggests a correlation between increased lipid deposition and impaired CYP enzyme function.
Conclusions:
- Fatty liver significantly impacts the liver's ability to metabolize drugs.
- Altered CYP enzyme expression and function are key consequences of steatosis.
- Understanding these mechanisms is crucial for managing patients with fatty liver disease.
Related Concept Videos
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...